Diabetic nephropathy and endothelial dysfunction: Current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study

Keyphrases

• Kinetic Study 100%
• Diabetic Nephropathy 100%
• Current Therapies 100%
• Endothelial Dysfunction 100%
• Intravascular Imaging 100%
• Future Therapies 100%
• Endothelium 66%
• Vasodilator 66%
• Nephropathy 33%
• Early Events 33%
• Type 2 Diabetes Mellitus (T2DM) 33%
• Molecular Mechanism 33%
• Modulatory 33%
• Nephropathic 33%
• Oxidative Modification 33%
• Experimental Animals 33%
• Therapeutic Strategies 33%
• Epigenetic Modification 33%
• Clinical Manifestations 33%
• Minimally Invasive 33%
• Microvasculature 33%
• Multispectral Optoacoustic Tomography 33%
• Drug Trials 33%
• Renal Thrombotic Microangiopathy 33%
• Associated Comorbidities 33%
• Diabetic Kidney Disease 33%

Medicine and Dentistry

• Angiography 100%
• Endothelial Dysfunction 100%
• Diabetic Nephropathy 100%
• Nephropathy 66%
• Vasoconstrictor 33%
• Photoacoustic Tomography 33%
• Drug Screening 33%
• Maturity Onset Diabetes of the Young 33%
• Vasodilator Agent 33%
• Microvessel 33%
• Microangiopathy 33%
• Epigenetic Modification 33%
• Comorbidity 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Endothelial Dysfunction 100%
• Diabetic Nephropathy 100%
• Kidney Disease 66%
• Experimental Animal 33%
• Drug Screening 33%
• Vasodilator Agent 33%
• Microangiopathy 33%
• Non Insulin Dependent Diabetes Mellitus 33%
• Comorbidity 33%